- Home
- CRNX vs CVLT Comparison
CRNX vs CVLT Comparison
Compare CRNX & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | CVLT |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CRNX | CVLT |
|---|---|---|
| Price | $33.97 | $119.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 18 |
| Target Price | $76.75 | ★ $139.53 |
| AVG Volume (30 Days) | ★ 1.2M | 616.5K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.58 |
| Revenue | $1,039,000.00 | ★ $1,183,690,000.00 |
| Revenue This Year | $720.10 | $13.29 |
| Revenue Next Year | $184.67 | $13.20 |
| P/E Ratio | ★ N/A | $76.93 |
| Revenue Growth | N/A | ★ 18.89 |
| 52 Week Low | $25.83 | $71.75 |
| 52 Week High | $57.99 | $200.68 |
Technical Indicators
Market Signals| Indicator | CRNX | CVLT |
|---|---|---|
| Relative Strength Index (RSI) | 40.12 | 67.84 |
| Support Level | $33.36 | $116.26 |
| Resistance Level | $37.23 | $129.23 |
| Average True Range (ATR) | 1.36 | 4.70 |
| MACD | -0.23 | 0.90 |
| Stochastic Oscillator | 29.09 | 80.18 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
About CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.